Published in Eur J Vasc Endovasc Surg on August 11, 2011
Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology (2014) 1.65
CCSVI and MS: a never-ending story. Eur J Vasc Endovasc Surg (2011) 1.43
CCSVI: is blinding the key? Eur J Vasc Endovasc Surg (2011) 1.38
What went wrong? The flawed concept of cerebrospinal venous insufficiency. J Cereb Blood Flow Metab (2013) 1.19
Screening for chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound: recommendations for a protocol. Funct Neurol (2012) 0.99
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free. Brain Behav (2014) 0.89
Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients. Funct Neurol (2012) 0.86
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. Neurol Sci (2013) 0.85
The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants. BMC Med (2013) 0.84
The fluctuating natural course of CCSVI in MS patients and controls, a prospective follow-up. PLoS One (2013) 0.81
Evaluating Necessity of Azygos Vein Ligation in Primary Repair of Esophageal Atresia. Indian J Surg (2013) 0.80
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores. Neurol Sci (2013) 0.79
CCSVI and MS: no meaning, no fact. Neurol Sci (2012) 0.79
Review of CCSVI and MS for EJVES. Eur J Vasc Endovasc Surg (2012) 0.75
Original Research: Feasibility and safety of two surgical techniques for the development of an animal model of jugular vein occlusion. Exp Biol Med (Maywood) (2016) 0.75
Comments regarding 'Venous angioplasty is safe to perform and may have benefits forin patients with multiple sclerosis. Results of a pilotcase control pilot study'. Eur J Vasc Endovasc Surg (2011) 0.75
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review. Pol J Radiol (2014) 0.75
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem (1977) 11.55
Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol (1985) 9.20
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2008) 5.35
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology (2011) 5.16
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology (2011) 3.62
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Complementation analysis of Klebsiella pneumoniae mutants defective in nitrogen fixation. Mol Gen Genet (1977) 3.17
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology (2004) 2.50
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Nitrogen fixation gene (nifL) involved in oxygen regulation of nitrogenase synthesis in K. pneumoniae. Nature (1981) 2.42
Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am J Physiol (1978) 2.34
Polarity of mutations induced by insertion of transposons Tn5, Tn7 and Tn10 into the nif gene cluster of Klebsiella pneumoniae. Mol Gen Genet (1978) 2.32
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) Neurology (1998) 2.16
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology (2010) 2.14
Linkage map of the nitrogen fixation (nif) genes in Klebsiella pneumoniae. Mol Gen Genet (1977) 2.10
Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test. Mult Scler (2007) 1.99
Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn (1992) 1.98
Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology (2011) 1.89
Thalamic atrophy and cognition in multiple sclerosis. Neurology (2007) 1.87
Eight-year follow-up study of brain atrophy in patients with MS. Neurology (2002) 1.78
The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation. J Immunol (1989) 1.76
A critical appraisal of review articles on the effectiveness of conservative treatment for neck pain. Spine (Phila Pa 1976) (2001) 1.76
The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol (1986) 1.72
Comparison of benefit to sugarcane plant growth and 15N2 incorporation following inoculation of sterile plants with Acetobacter diazotrophicus wild-type and Nif- mutants strains. Mol Plant Microbe Interact (2001) 1.71
Properties of the nuclear P1 protein, a mammalian homologue of the yeast Mcm3 replication protein. Nucleic Acids Res (1992) 1.71
P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol (1985) 1.71
Sequence and molecular analysis of the nifL gene of Azotobacter vinelandii. Mol Microbiol (1993) 1.69
The molybdenum--iron protein of Klebsiella pneumoniae nitrogenase. Evidence for non-identical subunits from peptide 'mapping'. Biochem J (1976) 1.68
Metabolic mapping of the primary visual system of the monkey by means of the autoradiographic [14C]deoxyglucose technique. Proc Natl Acad Sci U S A (1976) 1.68
Risk factors of multiple sclerosis: a case-control study. Neurol Sci (2003) 1.68
Regulation of nitrogen metabolism in Azotobacter vinelandii: isolation of ntr and glnA genes and construction of ntr mutants. EMBO J (1986) 1.68
Local cerebral blood flow during hibernation, a model of natural tolerance to "cerebral ischemia". J Cereb Blood Flow Metab (1994) 1.67
Telemedicine; here to stay. Med J Aust (1997) 1.63
The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol (2009) 1.62
Topographic mapping of electrophysiologic measures in patients with homonymous hemianopia. Neurology (1990) 1.61
Major depressive and post-traumatic stress disorder comorbidity in female victims of intimate partner violence. J Affect Disord (2001) 1.61
Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology (2010) 1.58
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) 1.57
Mental health service users' experiences of mental health care: an integrative literature review. J Psychiatr Ment Health Nurs (2015) 1.56
Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br J Pharmacol (1994) 1.53
A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis. Neurology (1998) 1.52
Expanding lacunae causing triventricular hydrocephalus. Report of two cases. J Neurosurg (1999) 1.52
Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2001) 1.51
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C. Leuk Res (2011) 1.50
Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain (2009) 1.50
Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature (1997) 1.48
Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch Neurol (1987) 1.48
Activation of nif gene expression in Azotobacter by the nifA gene product of Klebsiella pneumoniae. Nature (1983) 1.48
T cell recognition of HIV synthetic peptides in a natural infection. J Immunol (1989) 1.47
ATP produces vasodilation via P1 purinoceptors and vasoconstriction via P2 purinoceptors in the isolated rabbit central ear artery. Blood Vessels (1985) 1.46
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Corticospinal tract degeneration in motor neuron disease. AJNR Am J Neuroradiol (1995) 1.45
Cloning and mutagenesis of genes encoding the cytochrome bd terminal oxidase complex in Azotobacter vinelandii: mutants deficient in the cytochrome d complex are unable to fix nitrogen in air. J Bacteriol (1990) 1.45
Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol (1985) 1.43
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
Pyelonephritis, rash, and progressive respiratory failure in a pregnant woman. Clin Infect Dis (1992) 1.42
Mapping of functional neural pathways by autoradiographic survey of local metabolic rate with (14C)deoxyglucose. Science (1975) 1.42
Membranous obstruction of the inferior vena cava and Budd-Chiari syndrome. Report of a case. J Cardiovasc Surg (Torino) (1996) 1.41
Cognitive impairment related to conversion disorder: a two-year follow-up study. J Nerv Ment Dis (1993) 1.39
"Being dealt with as a whole person." Care seeking and adherence: the benefits of culturally competent care. Soc Sci Med (2001) 1.39
Mammographically negative breast cancer at the Strathfield Breast Centre. Aust N Z J Surg (1996) 1.38
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler (2009) 1.38
Endoscopic transvesical extramural ureterolithotomy. Br J Urol (1990) 1.37
Excretion of ammonium by a nifL mutant of Azotobacter vinelandii fixing nitrogen. Appl Environ Microbiol (1992) 1.35
Morphology of the femur in proximal femoral fractures. J Bone Joint Surg Br (1989) 1.33
Lessons from the program on chronic mental illness. Health Aff (Millwood) (1992) 1.33
Positive correlations between cerebral protein synthesis rates and deep sleep in Macaca mulatta. Eur J Neurosci (1997) 1.32
The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. J Infect Dis (1989) 1.32
The product of the nitrogen fixation regulatory gene nfrX of Azotobacter vinelandii is functionally and structurally homologous to the uridylyltransferase encoded by glnD in enteric bacteria. J Bacteriol (1991) 1.28
Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler (2006) 1.26
Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp (2007) 1.25
Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2012) 1.24
Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler (2003) 1.24
Expression of Klebsiella pneumoniae nitrogen fixation genes in nitrate reductase mutants of Escherichia coli. J Gen Microbiol (1977) 1.23
Identification and characterization of two nitrogen fixation regulatory regions, nifA and nfrX, in Azotobacter vinelandii and Azotobacter chroococcum. Mol Microbiol (1988) 1.22
Nitrogenase synthesis in Klebsiella pneumoniae: comparison of ammonium and oxygen regulation. J Gen Microbiol (1978) 1.21
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol (2001) 1.20
Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet (1997) 1.20
Oral health care and status of elderly care home residents in Glasgow. Community Dent Health (2007) 1.20
Mental health service use by Americans with severe mental illnesses. Soc Psychiatry Psychiatr Epidemiol (2000) 1.20
The Apgar score as an index of infant morbidity. A report from the collaborative study of cerebral palsy. Dev Med Child Neurol (1966) 1.19
Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry (2008) 1.19
Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens. Br J Pharmacol (1994) 1.18
P2X receptors in health and disease. Adv Pharmacol (2011) 1.18
Manual therapy for mechanical neck disorders: a systematic review. Man Ther (2002) 1.17
Local cerebral glucose utilization in the normal conscious macaque monkey. Ann Neurol (1978) 1.17
Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy. Acta Neuropathol (1988) 1.16
Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol (2010) 1.16
[Metastatic bone disease. Strategies for imaging]. Minerva Med (2003) 1.16
Cigar and pipe smoking related to four year survival of coronary patients. Br Heart J (1983) 1.16